We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Industry Leaders Provide an Update on COVID-19 Vaccine Progress
Industry Insight

A number of biopharmaceutical industry leaders met in a virtual press conference today to outline progress in COVID-19 vaccine development. Here's what they had to say.

Read More

A Conversation on Vaccine Hesitancy in COVID-19 Times
Industry Insight

Technology Networks spoke with Jeff Wolf, Heat Biologics CEO, to discuss what vaccine hesitancy is, why it is problematic and the steps that need to be taken to prevent vaccine hesitancy.

Read More

Diagnosing Vitamin B12 Deficiency Anemia
Industry Insight

Beckman Coulter has recently expanded their range of tools for anemia diagnosis, with the launch of the Access Active-B12 Assay. We spoke to Heather Read-Harper, European Senior Manager for Immunoassay and Clinical Chemistry at Beckman Coulter, to learn more about the assay and the advantages of detecting Active-B12.

Read More

Oral Vaccine for COVID-19 on Track Towards Human Clinical Trials
Industry Insight

Last week, Vaxart announced that it has selected its lead COVID-19 vaccine candidate, and has contracted with KindredBio to manufacture the vaccine in bulk. Technology Networks interviewed Walter Latour, MD, CEO and Chairman of Vaxart, to delve deeper into oral vaccine technology, the preclinical results for the oral candidates for COVID-19 and the next steps in this space.

Read More

Testing for SARS-CoV-2 Using Fingerprint Sweat
Industry Insight

Intelligent Fingerprinting and Imperial College London are working together to develop a rapid, non-invasive test for SARS-CoV-2, using a fingerprint-based method. To learn more about the project and the benefits a fingerprint test could offer, we spoke to Phil Hand, Executive Chairman, Intelligent Fingerprinting.

Read More

Developing Drugs for Difficult-to-treat Diseases
Industry Insight

Technology Networks recently spoke with Mike Sherman, Chief Executive Officer at Chimerix to learn more about the company’s oncology, biodefense and COVID-19 therapeutic efforts.

Read More

Improving Gene Editing by Promoting Error-free Repair of CRISPR/Cas9-cut DNA
Industry Insight

With the first clinical trial of CRISPR gene editing in progress and the controversy of the first gene-edited babies continuing to spark discussion, it is more important than ever to better understand not only the benefits but also the risks of CRISPR-based therapies.

Read More

Antibody Tests To Detect SARS-CoV-2 Immune Status
Industry Insight

We recently spoke with Shamiram Feinglass, Global Chief Medical Officer at Beckman Coulter, to learn more about antibody tests, what they can tell us, and the value of this information.

Read More

Real-time Antibody Titer Monitoring Advances Bioprocessing Capabilities
Industry Insight

In facilitating the move to continuous processing in biotherapeutic production, bioprocessing specialists are being driven to develop innovative analytical testing methods for key measurements of output and quality, such as antibody titer.

Read More

Tracking Global COVID-19 Clinical Trials
Industry Insight

In efforts to find efficacious interventions against SARS-CoV-2, the novel coronavirus that causes COVID-19, hundreds of clinical trials have been designed and launched at an unprecedented rate across the globe. As data emerges from these studies there is an urgent need to track progress, to ensure transparent communication of findings, and to avoid duplication of efforts. Technology Networks spoke with Cytel’s Edward Mills, Vice President of Real-World Evidence and Senior Principal Scientist, to learn more about the global COVID-19 Trial Tracker the company has recently launched.

Read More

 
Advertisement